J&J Drug Combo Shows Promise in Treating Lung Cancer
Johnson & Johnson's Rybrevant became the first medication for a particular subset of non-small cell lung cancer (NSCLC) in 2021.
Stay updated with breaking news from First Option. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Johnson & Johnson's Rybrevant became the first medication for a particular subset of non-small cell lung cancer (NSCLC) in 2021.
PAOLA — Lakemary Center recently added a new van to its fleet thanks to the Mary Agnes and Harold Scherman Charitable Trust through First Option Bank.
Nickel North Exploration Corp. wishes to provide an update on the previously announced option agreement with 1844 Resources Inc. , pursuant to which the Company has agreed to sell a 100% undivided interest in the Hawk Ridge nickel-copper project... - Veroeffentlicht am 17.08.2023
Backlog of $229 Million Added During Second QuarterOcean GreatWhite Completes Second Well Post-Reactivation; First Option ExercisedOcean BlackHawk Completes Senegal Contract; Commences Shipyard...
/PRNewswire/ -- Diamond Offshore Drilling, Inc. (NYSE: DO) today reported the following results for the second quarter of 2023: Three Months Ended Thousands of...